Basic Information
Basic information for LINC00343-236-16aa
Peptide Name LINC00343-236-16aa
Genome Position chr13:105707583-105707629,105718475-105718475[+]
Species Human
Peptide Sequence MQKELELPQGASKTLR
Peptide Length 16
Unique No (LINC00343-202-16aa,LINC00343-204-16aa-1,LINC00343-208-16aa,LINC00343-209-16aa,LINC00343-211-16aa,LINC00343-213-16aa,LINC00343-214-16aa,LINC00343-215-16aa,LINC00343-216-16aa,LINC00343-219-16aa,LINC00343-221-16aa,LINC00343-227-16aa,LINC00343-228-16aa,LINC00343-231-16aa,LINC00343-238-16aa,LINC00343-239-16aa,LINC00343-245-16aa,LINC00343-246-16aa,LINC00343-247-16aa,LINC00343-254-16aa,LINC00343-257-16aa,LINC00343-258-16aa,LINC00343-260-16aa-1,LINC00343-262-16aa,LINC00343-267-16aa,LINC00343-269-16aa,LINC00343-274-16aa,LINC00343-275-16aa,LINC00343-278-16aa,LINC00343-281-16aa,LINC00343-284-16aa,LINC00343-290-16aa,LINC00343-293-16aa,LINC00343-296-16aa,LINC00343-297-16aa,LINC00343-301-16aa,LINC00343-302-16aa,LINC00343-309-16aa,LINC00343-311-16aa,LINC00343-312-16aa,LINC00343-313-16aa,LINC00343-314-16aa,LINC00343-316-16aa,LINC00343-318-16aa,LINC00343-323-16aa,LINC00343-324-16aa,LINC00343-325-16aa,LINC00343-327-16aa,LINC00343-329-16aa,LINC00343-331-16aa)
Grand Average of Hydropathicity -0.9188
Relative Molecular Mass 2099.4
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000657324;LINC00343-236
Transcript Length 1643
Coding Ability 0.5435
DNA Sequence Corresponding to Peptide ATGCAAAAGGAATTAGAACTGCCACAAGGTGCAAGCAAAACCTTGAGG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :